Orthopedic procedure volumes improved more quickly than expected in the U.S., helping DePuy Synthes close 3Q20 down -2.6% compared to the prior year.

Startups must focus very tightly on a specific target market and value proposition to have the best chance of avoiding the doom loop of medtech innovation.

While the orthopedic market recovered faster than expected in the second quarter, we saw indications of deceleration heading into the third quarter.

CEO Nick Deeter says that 95% of children continue to receive adult orthopedic products that were never intended for them nor cleared by FDA for use in children. WishBone seeks to change the paradigm of pediatric orthopedics with its child-focused implants and sterile packaged disposable kits.

The company's exposure in global markets caused revenue declines of -24% in 1H20, but MicroPort launched several new products to spur future growth

The company grew in the high single digits for 1H20 as it benefited from provincial procurement tenders and the acquisition of Libeier.